Article Details

Aridis In-Licenses Pneumonia Candidate From AstraZeneca

Retrieved on: 2021-07-19 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

Aridis In-Licenses Pneumonia Candidate From AstraZeneca. View article details on hiswai:

Excerpt

Aridis Pharmaceuticals Inc (NASDAQ: ARDS) has entered into an exclusive, worldwide licensing agreement with AstraZeneca plc (NASDAQ: AZN) to ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up